More

    Price T Rowe Associates Inc. MD Sells 34,532 Shares of Cboe Global Markets, Inc. $CBOE

    Price T Rowe Associates Inc. MD decreased its holdings in shares of Cboe Global Markets, Inc. (NASDAQ:CBOEFree Report) by 5.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 624,279 shares of the company’s stock after selling 34,532 shares during the period. Price T Rowe Associates Inc. MD owned about 0.60% of Cboe Global Markets worth $141,269,000 as of its most recent SEC filing.

    Other institutional investors also recently added to or reduced their stakes in the company. Clearstead Trust LLC acquired a new position in shares of Cboe Global Markets in the 1st quarter worth approximately $26,000. NBC Securities Inc. acquired a new position in Cboe Global Markets during the first quarter worth $27,000. Hughes Financial Services LLC bought a new position in shares of Cboe Global Markets during the first quarter valued at $29,000. Cornerstone Planning Group LLC lifted its holdings in shares of Cboe Global Markets by 4,633.3% during the first quarter. Cornerstone Planning Group LLC now owns 142 shares of the company’s stock valued at $30,000 after acquiring an additional 139 shares during the period. Finally, Greenline Partners LLC acquired a new stake in shares of Cboe Global Markets in the 4th quarter valued at $29,000. 82.67% of the stock is owned by institutional investors and hedge funds.

    Cboe Global Markets Stock Performance

    CBOE stock opened at $246.43 on Monday. The company has a 50 day moving average price of $238.77 and a 200 day moving average price of $225.10. Cboe Global Markets, Inc. has a fifty-two week low of $187.30 and a fifty-two week high of $255.27. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.78 and a quick ratio of 1.39. The stock has a market capitalization of $25.77 billion, a PE ratio of 34.13, a price-to-earnings-growth ratio of 1.75 and a beta of 0.46.

    Cboe Global Markets (NASDAQ:CBOEGet Free Report) last released its earnings results on Friday, August 1st. The company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.43 by $0.03. Cboe Global Markets had a return on equity of 22.02% and a net margin of 18.64%.Cboe Global Markets’s revenue was up 14.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.15 earnings per share. Analysts forecast that Cboe Global Markets, Inc. will post 8.96 EPS for the current year.

    Cboe Global Markets Increases Dividend

    The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 29th will be given a $0.72 dividend. The ex-dividend date is Friday, August 29th. This is a positive change from Cboe Global Markets’s previous quarterly dividend of $0.63. This represents a $2.88 dividend on an annualized basis and a yield of 1.2%. Cboe Global Markets’s dividend payout ratio is 33.76%.

    Analyst Upgrades and Downgrades

    A number of brokerages recently issued reports on CBOE. Oppenheimer set a $265.00 target price on shares of Cboe Global Markets and gave the stock an “outperform” rating in a research report on Monday, August 4th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $254.00 price objective on shares of Cboe Global Markets in a report on Monday, August 4th. Citigroup boosted their target price on Cboe Global Markets from $230.00 to $245.00 and gave the stock a “neutral” rating in a report on Tuesday, July 8th. UBS Group restated a “neutral” rating and set a $255.00 price target (up from $245.00) on shares of Cboe Global Markets in a research report on Monday, August 4th. Finally, Cowen reiterated a “hold” rating on shares of Cboe Global Markets in a research report on Monday, May 5th. Two investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus target price of $231.38.

     

    Latest articles

    Related articles